Global pharmaceutical giant Eli Lilly & Co. is considering a $5.9 billion plant in northeast Houston, a potential economic ...

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out ...

Pharmaceutical manufacturing giant Eli Lilly and Co. is exploring potential economic incentives for a $5.9B biomanufacturing ...

Pharma giant Eli Lilly is planning a $5.9 billion investment for a massive pharmaceutical manufacturing facility in McCord ...

A major pharmaceutical manufacturing company is considering planting ground in Houston, with a $5.7 billion proposed ...

Eli Lilly has proposed investing $5.9 billion to build a pharmaceutical facility in Houston's Generation Park.

Lilly—a manufacturer of medicines like Mounjaro, Zepbound and Ebglyss—is considering purchasing 236 acres from Generation ...

HOUSTON — Eli Lilly & Co. (NYSE: LLY), one of the largest pharmaceutical manufacturers in the world, could be the latest major manufacturer moving into Houston. The Indianapolis-based drugmaker ...

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo ...